These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 8691261)

  • 1. Brain acetylcholinesterase activity: validation of a PET tracer in a rat model of Alzheimer's disease.
    Irie T; Fukushi K; Namba H; Iyo M; Tamagami H; Nagatsuka S; Ikota N
    J Nucl Med; 1996 Apr; 37(4):649-55. PubMed ID: 8691261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A simple method for the detection of abnormal brain regions in Alzheimer's disease patients using [11C]MP4A: comparison with [123I]IMP SPECT.
    Ota T; Shinotoh H; Fukushi K; Nagatsuka S; Namba H; Iyo M; Aotsuka A; Tanaka N; Sato K; Shiraishi T; Tanada S; Arai H; Irie T
    Ann Nucl Med; 2004 May; 18(3):187-93. PubMed ID: 15233279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetic analysis of [(11)C]MP4A using a high-radioactivity brain region that represents an integrated input function for measurement of cerebral acetylcholinesterase activity without arterial blood sampling.
    Nagatsuka Si S; Fukushi K; Shinotoh H; Namba H; Iyo M; Tanaka N; Aotsuka A; Ota T; Tanada S; Irie T
    J Cereb Blood Flow Metab; 2001 Nov; 21(11):1354-66. PubMed ID: 11702050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo evaluation of N-[18F]fluoroethylpiperidin-4ylmethyl acetate in rats compared with MP4A as a probe for measuring cerebral acetylcholinesterase activity.
    Kikuchi T; Okamura T; Zhang MR; Fukushi K; Irie T
    Synapse; 2010 Mar; 64(3):209-15. PubMed ID: 19862687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-[18F]fluoroethyl-4-piperidyl acetate ([18F]FEtP4A): A PET tracer for imaging brain acetylcholinesterase in vivo.
    Zhang MR; Furutsuka K; Maeda J; Kikuchi T; Kida T; Okauchi T; Irie T; Suzuki K
    Bioorg Med Chem; 2003 Jun; 11(12):2519-27. PubMed ID: 12757720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positron emission tomographic measurement of brain acetylcholinesterase activity using N-[(11)C]methylpiperidin-4-yl acetate without arterial blood sampling: methodology of shape analysis and its diagnostic power for Alzheimer's disease.
    Tanaka N; Fukushi K; Shinotoh H; Nagatsuka S; Namba H; Iyo M; Aotsuka A; Ota T; Tanada S; Irie T
    J Cereb Blood Flow Metab; 2001 Mar; 21(3):295-306. PubMed ID: 11295884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dementia with Lewy bodies can be well-differentiated from Alzheimer's disease by measurement of brain acetylcholinesterase activity-a [11C]MP4A PET study.
    Shimada H; Hirano S; Sinotoh H; Ota T; Tanaka N; Sato K; Yamada M; Fukushi K; Irie T; Zhang MR; Higuchi M; Kuwabara S; Suhara T
    Int J Geriatr Psychiatry; 2015 Nov; 30(11):1105-13. PubMed ID: 26280153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-[18F] fluoroethylpiperidin-4ylmethyl acetate, a novel lipophilic acetylcholine analogue for PET measurement of brain acetylcholinesterase activity.
    Kikuchi T; Zhang MR; Ikota N; Fukushi K; Okamura T; Suzuki K; Arano Y; Irie T
    J Med Chem; 2005 Apr; 48(7):2577-83. PubMed ID: 15801847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A method to predict the ratio of the tracer conversion rate to the tracer back-diffusion rate of an irreversible-type radiotracer in humans by preclinical evaluations.
    Ohya T; Zhang MR; Fukumura T; Fukushi K; Kikuchi T; Irie T
    Nucl Med Commun; 2012 Oct; 33(10):1019-23. PubMed ID: 22850605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positron emission tomography: quantitative measurement of brain acetylcholinesterase activity using radiolabeled substrates.
    Namba H; Fukushi K; Nagatsuka S; Iyo M; Shinotoh H; Tanada S; Irie T
    Methods; 2002 Jul; 27(3):242-50. PubMed ID: 12183113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-vivo measurements of regional acetylcholine esterase activity in degenerative dementia: comparison with blood flow and glucose metabolism.
    Herholz K; Bauer B; Wienhard K; Kracht L; Mielke R; Lenz MO; Strotmann T; Heiss WD
    J Neural Transm (Vienna); 2000; 107(12):1457-68. PubMed ID: 11458998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Voxel-Based Acetylcholinesterase PET Study in Early and Late Onset Alzheimer's Disease.
    Hirano S; Shinotoh H; Shimada H; Ota T; Sato K; Tanaka N; Zhang MR; Higuchi M; Fukushi K; Irie T; Kuwabara S; Suhara T
    J Alzheimers Dis; 2018; 62(4):1539-1548. PubMed ID: 29562505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain acetylcholinesterase activity in mild cognitive impairment and early Alzheimer's disease.
    Rinne JO; Kaasinen V; Järvenpää T; Någren K; Roivainen A; Yu M; Oikonen V; Kurki T
    J Neurol Neurosurg Psychiatry; 2003 Jan; 74(1):113-5. PubMed ID: 12486280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo study of acetylcholine esterase in basal forebrain, amygdala, and cortex in mild to moderate Alzheimer disease.
    Herholz K; Weisenbach S; Zündorf G; Lenz O; Schröder H; Bauer B; Kalbe E; Heiss WD
    Neuroimage; 2004 Jan; 21(1):136-43. PubMed ID: 14741650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human cerebral acetylcholinesterase activity measured with positron emission tomography: procedure, normal values and effect of age.
    Namba H; Iyo M; Fukushi K; Shinotoh H; Nagatsuka S; Suhara T; Sudo Y; Suzuki K; Irie T
    Eur J Nucl Med; 1999 Feb; 26(2):135-43. PubMed ID: 9933347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of acetylcholinesterase by positron emission tomography in the brains of healthy controls and patients with Alzheimer's disease.
    Iyo M; Namba H; Fukushi K; Shinotoh H; Nagatsuka S; Suhara T; Sudo Y; Suzuki K; Irie T
    Lancet; 1997 Jun; 349(9068):1805-9. PubMed ID: 9269216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo brain incorporation of [1-14C]arachidonate in awake rats, with or without cholinergic stimulation, following unilateral lesioning of nucleus basalis magnocellularis.
    Nariai T; DeGeorge JJ; Lamour Y; Rapoport SI
    Brain Res; 1991 Sep; 559(1):1-9. PubMed ID: 1723641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PET probes for imaging brain acetylcholinesterase.
    Kikuchi T; Okamura T; Zhang MR; Irie T
    J Labelled Comp Radiopharm; 2013; 56(3-4):172-9. PubMed ID: 24285323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acetylcholinesterase imaging: its use in therapy evaluation and drug design.
    Shinotoh H; Fukushi K; Nagatsuka S; Irie T
    Curr Pharm Des; 2004; 10(13):1505-17. PubMed ID: 15134572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term effects of selective immunolesions of cholinergic neurons of the nucleus basalis magnocellularis on the ascending cholinergic pathways in the rat: a model for Alzheimer's disease.
    Szigeti C; Bencsik N; Simonka AJ; Legradi A; Kasa P; Gulya K
    Brain Res Bull; 2013 May; 94():9-16. PubMed ID: 23357177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.